ILD is a dubious disease in the field of infectious respiratory digestive and endocrine disorders, with complex clinical outcomes and often involving multi-system congestion. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging inspections, laboratory tests and pathological activation.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of pulmonary fibromyalgia ILD requires personalized development of treatment programs, which typically include drug therapy, rehabilitation interventions, and follow-up multidimensional management. In recent years, with the development of therapeutically oriented, immune-regulatory therapies and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have improved significantly.
Therapeutic efficacy and adverse reactions need to be closely monitored during treatment and timely adjusted according to changes in the condition. The platform serves the China International Medical Service System, which combines domestic and foreign authoritative teams of experts in the field of infectious respiratory digestive and endocrine secretion to provide the following services to patients: 1. Remote pre-diagnosis: pre-examination of medical records, precise diagnostic directions and medical advice by the team of experts; 2.
Interviews in China: arrangements with authoritative experts for face-to-face diagnosis, development of personalized treatment programs; 3. Full-service: one-stop services: medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishment of a chronic disease management file, continuous monitoring of changes in disease and treatment effects.
Support for remote pre-diagnosis, visiting interviews, full translation and escort.